ASCO Daily News

134 Episoade

1. Day 4: Top Takeaways From ASCO24

   Publicat: 03.06.2024
2. Day 3: Top Takeaways From ASCO24    

   Publicat: 02.06.2024
3. Day 2: Top Takeaways From ASCO24

   Publicat: 01.06.2024
4. Day 1: Top Takeaways From ASCO24  

   Publicat: 31.05.2024
5. Exploring CAR T Cells in GI Cancers at ASCO24

   Publicat: 25.05.2024
6. Key Abstracts in GU Cancers at ASCO24

   Publicat: 25.05.2024
7. ASCO24: The Future of Personalized Immunotherapy

   Publicat: 24.05.2024
8. Novel Approaches in Hematologic Malignancies at ASCO24

   Publicat: 24.05.2024
9. Spotlight on Breast Cancer at ASCO24

   Publicat: 23.05.2024
10. ASCO24: The Era of the ADCs in NSCLC

    Publicat: 23.05.2024
11. Optimizing Novel Therapies and Surgery in Early-Stage NSCLC

    Publicat: 25.04.2024
12. A Revolution in Immunotherapy for Cervical and Endometrial Cancers

    Publicat: 18.04.2024
13. How ctDNA Is Advancing Care for Patients With GI Cancers

    Publicat: 04.04.2024
14. New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity

    Publicat: 21.03.2024
15. Innovations in CAR T-Cell Therapy for Multiple Myeloma

    Publicat: 07.03.2024
16. ADCs in Breast Cancer: Sequencing, Resistance, and Managing Toxicity

    Publicat: 15.02.2024
17. Advances in Precision Oncology for GI Cancers at GI24

    Publicat: 08.02.2024
18. Key Advances in Prostate, Kidney, and Bladder Cancers at GU24

    Publicat: 06.02.2024
19. What’s New in Prostate Cancer, RCC, and mUC at GU24

    Publicat: 22.01.2024
20. Celebrating 20 Years of Evolution in GU Oncology

    Publicat: 14.12.2023